[Oral anticoagulation with vitamin K antagonists]
- PMID: 12638470
- DOI: 10.1024/0040-5930.60.1.5
[Oral anticoagulation with vitamin K antagonists]
Abstract
Coumarins are broadly employed in clinical practice and should therefore belong to the group of 'well known' drugs. The present review will deal with some concepts of anticoagulant therapy: the role of vitamin K in the synthesis of functional coagulation factors, some clinically relevant pharmacokinetic aspects of coumarins, the management of oral anticoagulant therapy with special emphasis on the laboratory monitoring, and the most frequent complication, bleeding.
Similar articles
-
The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.Thromb Res. 2008;123(2):225-30. doi: 10.1016/j.thromres.2008.01.020. Epub 2008 Apr 14. Thromb Res. 2008. PMID: 18407321 Clinical Trial.
-
Phenprocoumon and acenocoumarol treatment in paediatric patients.Thromb Haemost. 2012 Dec;108(6):1238-41. doi: 10.1160/TH12-04-0242. Epub 2012 Sep 26. Thromb Haemost. 2012. PMID: 23014894 No abstract available.
-
[Anticoagulation by oral treatment with vitamin K antagonists].Hamostaseologie. 2008 Dec;28(5):421-7. Hamostaseologie. 2008. PMID: 19132171 German.
-
[Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].Wien Med Wochenschr. 2008;158(21-22):615-20. doi: 10.1007/s10354-008-0610-3. Wien Med Wochenschr. 2008. PMID: 19052707 Review. German.
-
Reversal of vitamin K antagonists prior to urgent surgery.Can J Anaesth. 2010 May;57(5):458-67. doi: 10.1007/s12630-009-9250-3. Epub 2010 Jan 15. Can J Anaesth. 2010. PMID: 20077167 Review.
Cited by
-
Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model.Clin Pharmacokinet. 2013 May;52(5):359-71. doi: 10.1007/s40262-013-0043-z. Clin Pharmacokinet. 2013. PMID: 23519598 Clinical Trial.
-
Pharmacogenetics of oral anticoagulants: a basis for dose individualization.Clin Pharmacokinet. 2008;47(9):565-94. doi: 10.2165/00003088-200847090-00002. Clin Pharmacokinet. 2008. PMID: 18698879 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical